Clinical study on Acupuncture treatment of Hypertension with Hyperactivity of liver-Yang

Dongzhimen Hospital of Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18 to 65 years old male and female;
•2. In accordance with the diagnostic criteria of essential hypertension in the 2018 revised Chinese guidelines for the Prevention and treatment of Hypertension, patients with grade 1 and 2 low, moderate and high-risk hypertension have regularly taken less than 2 kinds of antihypertensive drugs for more than 2 months, and their blood pressure is stable at the normal high value without much fluctuation. The main object of study was (SBP >=130 mmHg, DBP >=80 mmHg);
•3. meet the diagnostic standard of hyperactivity of liver-yang in hypertension;
•4. They have not received acupuncture treatment in the past one month;
•5. It has a correct understanding of the significance of the clinical research and has a good compliance with the observation and evaluation of the researchers;
•6. The informed consent form was signed by the patient himself or by the immediate family members of the patient.

•1. Secondary hypertension such as aldosteronism, pheochromocytoma, Cushing syndrome, pregnancy hypertension and so on;
•2. Patients with other serious complications such as cardio-cerebral vessels, kidney, retina, peripheral blood vessels, diabetes, blood diseases, etc., which are not suitable for acupuncture treatment;
•3. Patients with skin diseases and skin damage at the tested acupoints;
•4. Women with mental illness or pregnancy or lactation;
•5. Complicated with diagnosed epilepsy, obstructive sleep apnea hypopnea syndrome and so on;
•6. Those who are participating in other clinical trials.

发起方

Dongzhimen Hospital of Beijing University of Chinese Medicine